These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 32338423

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.
    Lillicrap D, Schiviz A, Apostol C, Wojciechowski P, Horling F, Lai CK, Piskernik C, Hoellriegl W, Lollar P.
    Haemophilia; 2016 Mar; 22(2):308-317. PubMed ID: 26278557
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM, Franchini M.
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [Abstract] [Full Text] [Related]

  • 26. Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review.
    Hayden A, Candelario N, Moyer G.
    Res Pract Thromb Haemost; 2022 Feb; 6(2):e12688. PubMed ID: 35356668
    [Abstract] [Full Text] [Related]

  • 27. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
    Salaj P, Geierová V, Ivanová E, Loužil J, Pohlreichová V, Hrachovinová I, Dulíček P.
    Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
    [Abstract] [Full Text] [Related]

  • 28. Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.
    Négrier C, Oldenburg J, Kenet G, Meeks SL, Bordet JC, Müller J, Le Quellec S, Turecek PL, Tripkovic N, Dargaud Y.
    Res Pract Thromb Haemost; 2022 May; 6(4):e12731. PubMed ID: 35765670
    [Abstract] [Full Text] [Related]

  • 29. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I.
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anti-inhibitor coagulant complex for the rescue therapy of acquired inhibitors to factor VIII: case report and review of the literature.
    Kleinman MB.
    Haemophilia; 2002 Sep; 8(5):694-7. PubMed ID: 12199681
    [Abstract] [Full Text] [Related]

  • 35. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E, Collecutt M, Street A.
    Methods Mol Biol; 2013 Sep; 992():321-33. PubMed ID: 23546724
    [Abstract] [Full Text] [Related]

  • 36. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M.
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Experience with recombinant factor VIIA in an infant hemophiliac with inhibitors to FVIII:C undergoing emergency central line placement. A case report.
    Bell BA, Birch K, Glazer S.
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):77-9. PubMed ID: 8447562
    [Abstract] [Full Text] [Related]

  • 39. Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII.
    Green D, Blanc J, Foiles N.
    J Lab Clin Med; 1999 Mar; 133(3):260-4. PubMed ID: 10072258
    [Abstract] [Full Text] [Related]

  • 40. Innovative use of porcine factor VIII:C for immune tolerance induction.
    Hay CR.
    Am J Med; 1991 Nov 04; 91(5A):27S-29S. PubMed ID: 1746593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.